CLARE ROSS: Open Payments
NPI 1518959261 · QUEENSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 37 payments from 18 companies in 2025. Trend: 2023 $1,003 · 2024 $1,583 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $143 |
| PFIZER INC. | 6 | $118 |
| Amgen Inc. | 4 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| SCPHARMACEUTICALS INC. | 3 | $47 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Novo Nordisk Inc | 2 | $36 |
| Abbott Laboratories | 1 | $30 |
Products named: LifeVest, Kerendia, ELIQUIS, REPATHA, LEQVIO, VYNDAQEL, FUROSCIX, VERQUVO.
Industry payments across MD — which companies pay providers there.
